|
|
||||||||
J Biol Chem, Vol. 274, Issue 44, 31333-31340, October 29, 1999
From the Department of Pathology and the Center for Immunology,
Washington University School of Medicine,
St. Louis, Missouri 63110
The complex of the murine class II
histocompatibility molecules I-Ak with high affinity
binding peptides were resistant to denaturation when examined by
SDS-polyacrylamide gel electrophoresis at various pH levels. In
contrast, complexes made with low affinity binding peptides were highly
sensitive to denaturation by SDS. This effect was more pronounced at
low pH. Placing a photoactivatable probe at the amino terminus of the
peptides resulted in their covalent linkage to soluble I-Ak
molecules. We found an inverse relationship between the capacity of
peptides to form SDS-stable complexes with I-Ak and their
extent of covalent association with either the We have been examining the interaction of peptides with class II
major histocompatibility complex
(MHC)1 molecules, attempting
to relate binding interactions to biological responses. Here, we
examine the degree to which a peptide has conformational flexibility
when bound to a class II MHC molecule. This aspect can be important to
its fate during intracellular traffic and during its interaction with a
T cell. To examine this point, we analyzed peptide-MHC complexes using
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), evaluating the
effects of pH on the resistance or susceptibility to denaturation.
Importantly, we used photoactivatable peptides, to examine their
restriction or freedom to covalently link to MHC molecules. Finally, we
also examined the protease sensitivity of various peptide-MHC complexes.
We, as well as other laboratories, examined the behavior of the ternary
complexes of peptides with the The biological significance of the two sets of SDS complexes is
uncertain. We correlated the time of persistence of the complexes in
the antigen-presenting cell (APC) with the SDS state (11, 12). For
example, using metabolically labeled I-Ak, the time of
persistence of a peptide-MHC complex was the result of two components:
a long t1/2 was represented in the SDS-stable
fraction, whereas a short t1/2 (about We now describe further analysis of a dominant antigenic peptide, the
peptide at residues 48-61 of hen egg white lysozyme, when bound to
I-Ak molecules. This peptide (DGSTDYGILQINSR)
binds strongly to I-Ak as a result of the interaction of
Asp-52 (underlined above) with the P1 binding site of I-Ak
(6, 7). We examined peptides in which we changed this P1 anchor residue
from aspartic acid to other amino acids that reduced their binding
strength and SDS-PAGE behavior. These peptides were bound to
I-Ak, and the complexes were tested, first, for the effects
of the pH on their SDS resistance or susceptibility and, second, for their interaction using photoactivatable 48-61 peptides. These analysis suggest that the complexes of peptide-I-Ak have
two structural states of interaction, as was revealed by the extent of
freedom of the amino terminus of the peptide bound to I-Ak.
In one, the peptide is bound in a more fixed structure resistant to SDS
denaturation, in which the amino terminus of the peptide binds poorly
to the I-Ak class II molecule. In the second, the peptide
is bound in a structure sensitive to SDS denaturation in which the
peptide has freedom at its amino terminus and efficiently binds the
I-Ak molecule. The I-Ak peptide complexes
resistant to SDS denaturation are likewise highly resistant to
proteolytic enzymes, in contrast to those sensitive to SDS denaturation.
I-Ak Purification--
The class II molecule
I-Ak was purified from the cell line T-2 expressing
I-Ak. I-Ak molecules were isolated from cell
lysates by affinity chromatography, using Sepharose 4B coupled with 40F
(anti-I-Ak) antibody as described previously (13). Eluted
material was purified by reverse phase high pressure liquid
chromatography (HPLC) with a Bio-gel TSK 250 filtration column
(Bio-Rad) equilibrated with phosphate-buffered saline (PBS) containing
20 mM Mega 8, 20 mM Mega 9.
Peptides--
Peptides were synthesized by Fmoc
(N-(9-fluorenyl)methoxycarbonyl) technology on an Applied
Biosystem peptide synthesizer, purified by reverse phase HPLC using a
C18 Vidac column and analyzed by mass spectrometry (6). Peptides were
labeled with Na125I to a specific activity of 2-4 × 109 cpm/µmol by the chloramine T method and purified on
reverse phase HPLC using a C18 Vidac column.
Preparation of
IASA-Peptide--
N-Hydrosysuccinidimyl-4-azidosalicylic
acid (NHS-ASA) (Pierce) was labeled with Na125I by the
chloramine T method. The radiolabeled compound was covalently conjugated at the peptide amino terminus, as described previously (13-16) and the complex (IASA-peptide) was purified by reverse phase
HPLC using a C18 Vidac column. The main radioactive peak was collected,
dried, dissolved in PBS, and used for binding assays.
Assays to Test Effect of pH--
Purified I-Ak (25 nmol) was incubated for 48 h at room temperature with 25 pmol of
radiolabeled peptide in a solution of PBS containing 20 mM
Mega 8, 20 mM Mega 9, 5 mM
lysophosphatidyl-choline, 300 mM 4-morpholineethanesulfonic
acid (MES) buffer, pH 5.5, in a final volume of 25 µl (14). Complexes
were recovered by gel filtration using a Bio-Spin P6 column (6-kDa
cut-off) (Bio-Rad) equilibrated with PBS, pH 7.4, containing 20 mM Mega 8, 20 mM Mega 9. Then, 10 µl of the
complexes (usually 1000-1500 cpm/µl) were incubated with 10 µl of
a solution containing 40 mM MES at the indicated pH (from
5.5 to 7.5) for 15 min at room temperature; 20 µl of a 2% SDS
aqueous solution was then added, and the mixture was incubated for 45 min at room temperature. Finally, complexes were neutralized with 40 µl of a solution containing 250 mM Tris, pH 7.0, 1.44 M 2 Binding Assay and Immunoprecipitation of
IASA-peptide-I-Ak Complexes--
Purified I-Ak
(25 nmol) was incubated for 48 h at room temperature with 25 pmol
of IASA-peptide in a solution of PBS containing 20 mM Mega
8, 20 mM Mega 9, 5 mM lysophosphatidylcholine,
300 mM MES, pH 5.5, in a final volume of 25 µl. The
complexes (~106 cpm) were recovered by gel filtration on
a column equilibrated with PBS, pH 7.4, containing 20 mM
Mega 8, 20 mM Mega 9, ultraviolet light-irradiated for 2 min at 340 nm, and then immunoprecipitated with 40F antibody (11, 13)
followed by protein A-Sepharose. The Sepharose-bound
I-Ak-peptide complexes were eluted at room temperature for
1 h with 62.5 mM Tris, pH 6.8, 0.77 M
2-
Under nonboiling conditions, a photolabeled peptide that is covalently
linked to an SDS-stable complex will migrate at around 50 kDa, the
position of the Assays to Test the Effects of Proteolytic Enzymes--
Three
assays were set up. First, 125I-labeled 48-61 peptides
were incubated with I-Ak, as described above. After 48 h, the I-Ak peptide complex was separated from free peptide
using a Bio-Rad P6 column and placed at 37 °C in appropriate buffer
solution with or without the following enzymes: chymotrypsin (Sigma
product C7762), in 0.5 M Tris buffer with 1% Triton X-100,
at pH 7.8; Cathepsin B (Sigma product C6286) in 50 mM
sodium acetate, 1% Triton X-100, 1 mM dithiothreitol, pH
5.5, and cathepsin D (Sigma product C31381) in 50 mM sodium
acetate, 1% Triton X-100, 1 mM EDTA, pH 5.5. The final
incubation was done in 100-150 µl of solution that contained 50 µg
of the I-Ak molecule per ml with the enzymes at the
concentrations stated in the figures. At various time points, the
complexes were again passed through a BioSpin P6 column to
determine the amount of radioactivity associated with
I-Ak.
In the second assay, the complexes were isolated after 2 h of
incubation in chymotrypsin using the monoclonal antibody 40F-bound to
Sepharose 4B. (To 500 µl solution containing about 2 nmol of I-Ak was added 50 µl of a 50% (v/v) slurry of the 40F
antibody bound to Sepharose 4B. The beads had been conjugated using
cyanogen bromide with 10 mg/ml protein to 1 ml of Sepharose 4B slurry.) After 2 h, the Sepharose particles were washed twice and placed in
500 µl of 0.1% trifluoroacetic acid. Beads were removed, and the
radioactive peptide examined by reverse phase HPLC in a Waters system
with a C18 reverse phase column (Vidac 2187P54, Hespevia, CA), at a
flow rate of 1 ml/min and a gradient of acetonitrile in trifluoroacetic
acid (from 0 to 80% acetonitrile in 0.05% trifluoroacetic acid, for
60 min).
Third, the I-Ak molecules from APCs were labeled with
[35S]methionine and then examined by SDS-PAGE. Cells from
a B lymphoma line that expresses both I-Ak molecules and
hen egg white lysozyme (5) were resuspended at 107 cells/ml
in Dulbecco's minimal essential medium lacking methionine and cysteine
and containing 5% dialyzed fetal calf serum. The cells were incubated
with 200 µCi of 35S-labeled methionine and cysteine
(Trans-35S-label from ICN, Irvine, CA) in 1 ml for 1 h, after which the culture was made in 1 mg/ml methionine, 0.5 mg/ml
cysteine, and 10% fetal calf serum and incubated for 4 h more.
Cells were harvested and lysed in PBS containing 20 mM Mega
8, 20 mM Mega 9, 10 mM iodoacetamide, 25 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride.
Cell lysates were cleared by centrifugation and immunoprecipitated with
the antibody 40F-Sepharose 4B. The I-Ak molecules were
eluted with a buffer solution of 0.1 M diethylamine, 0.15 M sodium chloride, and 20 mM each Mega 8 and
Mega 9 at pH 10.65. The eluate was concentrated in a Centricon 30 tube
(Amicon, Inc., Beverly, MA) and incubated with chymotrypsin at 37 °C
for 2 h. The material was then subjected to SDS-PAGE, as described above. The intensity of each band was quantitated in a PhosphorImager.
Most of the results shown in this study were made using the 48-61
peptide of hen egg white lysozyme (DGSTDYGILQINSR) bound to
I-Ak, using variants in which the main anchor residue for
the P1 pocket was changed in order to weaken the affinity of the
peptide for the I-Ak class II molecule (i.e. Asp
at 52). In general, peptides with a weak anchor residue yielded a
complex with I-Ak that was less stable under SDS-PAGE
conditions. A summary of our previous results (4, 5), as well as those
obtained in this study, is shown in Table
I. We first report on the SDS-PAGE stability of the various I-Ak-peptide complexes and the
influence that pH has on this assay. We next consider the use of
peptides containing a photoactivatable probe: we examine the extent of
covalent linkage of the peptides to I-Ak using the SDS-PAGE
readout. Finally, we examine the protease sensitivity of the
complexes.
Effect of pH on SDS-PAGE stability of I-Ak-Hen Egg
White Lysozyme Peptide Complexes--
Purified I-Ak
molecules were incubated with radiolabeled peptides at pH 5.5, the
optimal pH for their binding (17), for 48 h; the complexes were
isolated by gel filtration, incubated at the indicated pH solution for
15 min and then for 45 min with 1% SDS, and finally subjected to the
SDS-PAGE. (Note that in all these assays, the complex of
I-Ak with peptides was not subjected to a
100 °C temperature. Boiling the complex resulted in the dissociation
of the
Fig. 1, top panels, shows that
the peptide 48-61 bound to I-Ak forms highly SDS-stable
complexes, independent of the pH of incubation. In other experiments,
we found that the stability of these complexes persisted in 2% SDS for
as long as 6 h. In contrast, complexes formed with 48-61 having a
substitution of leucine for aspartic acid at residue 52 (Table I) (4,
5) were highly SDS-unstable (Table I), regardless of pH, SDS
concentration, and time of incubation (Fig. 1, bottom
panels).
We analyzed three other 48-61 peptides having serine, threonine, or
glutamine at position 52, which led to intermediate binding affinities
to I-Ak molecules (Table I). As shown in Fig.
2, the SDS stability of the three
complexes was influenced by pH. At mildly acidic pH (5.5-6.5), the
complexes were mostly unstable (0-31%). At pH 7.0 or 7.5, the
complexes became resistant to denaturation (58-84%) (Fig. 2).
Analysis of the Interaction between IASA-Peptides and
I-Ak Molecules by Photoaffinity Labeling--
Peptides
were conjugated at the amino terminus with the radiolabeled
photoactivatable probe IASA. The IASA-48-61 peptide and its variants
at residue 52 were incubated with I-Ak: the complexes were
recovered and subjected to ultraviolet irradiation, in order to
covalently cross-link the peptide into the class II molecule, and then
analyzed by SDS-PAGE.
In a previous study, we showed that IASA-46-61 bound to
I-Ak was cross-linked to the
In the experiment shown in Fig. 3, a
photolabeled-bound peptide that forms an SDS-unstable complex runs by
SDS-PAGE in the position of the
A photolabeled-bound peptide that forms an SDS-stable complex
(i.e. with 48-61 or 46-61) will run at the position of the
stable
This different capacity between the stable and unstable complexes to
cross-link was more dramatically shown with the 48-61 Ser-52 or 48-61
Thr-52 peptides. These peptides were subjected to SDS-PAGE as a mixture
of stable and unstable complexes (Fig. 3). Only a percentage of the
complexes were covalently associated with the
We also examined two other peptides that bind to I-Ak
(4-6). A peptide from hsp70 residues 28-41 is found normally bound to I-Ak molecules extracted from APCs. This peptide also had
an aspartic acid residue anchoring it to the P1 pocket, at residue 32, and when bound to I-Ak molecules ran stable by SDS-PAGE. As
before the stable complexes were poorly cross-linked (Fig.
4). Substituting an alanine at the P1
anchor site of residue 32 resulted in weak binding, and an increase in
SDS unstable complexes, that was covalently linked to the Sensitivity to Proteolysis of the Peptide-MHC
Complexes--
Considering the possible biological consequences of the
two states of peptide-MHC complexes described above, we examined their degree of sensitivity to proteolytic enzymes. We reasoned that the
SDS-stable complexes, which were assumed to have a more fixed or rigid
structure, could be more resistant to proteolysis. In contrast, those
with the SDS-unstable conformation, i.e. with a more
flexible conformation, would be sensitive. If so, these states could
reflect in the fate of the complexes in the proteolytic-rich vesicles
of the APC.
Radiolabeled peptides were bound to I-Ak, after which the
complexes were isolated and then incubated at 37 °C with
chymotrypsin or the lysosomal enzyme cathepsin B or D. The time of
dissociation of the peptide from I-Ak varied, in part
dependent on the binding strength of the peptide, an issue studied
before (5). The complex of I-Ak-48-61 was highly resistant
to each of the enzymes. A representative experiment is shown in Fig.
5. Even the very large concentration of
10 mg/ml chymotrypsin did not change the time of dissociation of the
peptide from the MHC molecule. Confirming previous results (18, 19),
48-61 bound to I-Ak was highly stable with prolonged time
of dissociation. We proceeded to recover the peptide from
I-Ak after 2 h in chymotrypsin and to examine it by
HPLC: the I-Ak-peptide complex was recovered, isolated
using antibodies bound to Sepharose beads, and washed; then, its
components were dissociated, and the 125I peptide was
examined by reverse phase HPLC. The peptide was not affected, eluting
in the same fraction as the untreated peptide (Fig.
6). Thus, in agreement with previous
reports, the 48-61 peptide, which can be cleaved by chymotrypsin in
free solution, is now resistant to the enzyme during the time that it
is bound to I-Ak molecules. (Likewise, cathepsin B and
cathepsin D, even at 10 units/ml, did not affect the amount of peptide
bound after 3 h; i.e. relative to control, the amounts
of 48-61 lost were 2.5 and 1.9%, respectively.
The complex formed with 48-61 Ser-52 was slightly more sensitive to
chymotrypsin and to the cathepsins (Fig. 5). Even at 5 mg/ml
chymotrypsin, the amounts lost at 6 h did not exceed 25% of the
bound peptide. As with 48-61, the peptide bound to I-Ak
was shown not to be cleaved when recovered from I-Ak
molecules (Fig. 6). (The amounts lost after 3 h in 10 units/ml cathepsin B or cathepsin D were 7.8 and 5.2%, respectively.)
The complexes formed with 48-61 Leu-52 and 48-61 Ala-52 were highly
sensitive to chymotrypsin (Fig. 5). Note in Fig. 5 that the loss of
48-61 Leu-52 was affected at a 10 µg/ml concentration of enzyme.
Also to note is that the peptide that remained bound to
I-Ak was still protected from chymotrypsin cleavage (Fig.
6). (The complexes were likewise sensitive to cathepsin B and cathepsin D. Thus, about half of the complexes at 3 h were lost with a 10 unit/ml concentration of either cathepsin.)
All of the peptides were protected from chymotrypsin action during the
time that they remained associated with I-Ak, yet the
enzyme dissociated the complexes, particularly with 48-61 Leu-52 and
48-61 Ala-52. Similar results were obtained with two synthetic
peptides based on the 48-61 sequence but modified so as to make them
resistant to chymotrypsin. Peptide AGSTDAGAAAQANSKY bound to
I-Ak with about the same strength as 48-61 (relative
inhibitory capacity
We examined whether SDS-stable or unstable I-Ak molecules
from APCs labeled with 35S showed a differential
sensitivity to chymotrypsin. Cells were pulsed with
35S-labeled methionine/cysteine and then incubated for
6 h, after which the I-Ak molecules were isolated and
treated with the enzyme (Fig. 7). About
half of the labeled molecules from untreated samples were SDS-stable,
and this number increased when the protein was treated with
chymotrypsin (from 58 to 87%). The absolute value of the SDS-stable
band did not change after treatment with chymotrypsin. However, there
was a selective loss of the SDS-unstable molecules when treated with
the enzyme chymotrypsin. At 0.010 mg/ml chymotrypsin, 48% of the
radioactive bands corresponding to the SDS-unstable component were
already lost.
This study emphasizes the influence that key amino acid anchor
residues have on the properties of peptide-MHC complexes in which two
sets of interactions were identified. One was represented by peptides
that bound to I-Ak with low affinity and had a higher
tendency for denaturation by SDS, particularly at low pH. Such peptides
were extensively bound by the photoactivatable probe, placed at their
amino terminus. In sharp contrast, the complexes of I-Ak
and high affinity binding peptides were resistant to SDS, regardless of
the pH, and were poorly cross-linked by the photoprobe. These results
indicate to us that the complexes formed with weak binding peptides
have more conformational freedom: the amino end, which extends beyond
the combining site, is free to search for binding sites during the time
of their activation. In contrast, the high affinity binding peptides
favor a more rigid structure that places the molecule in a more fixed
conformation. In agreement with this interpretation are the results
showing the differential sensitivity to proteases of the two sets of
I-Ak-peptide complexes.
The differences in SDS denaturation at low pH between the two sets of
complexes might reflect a higher or lesser exposure of hydrophobic
residues brought about by the pH change (20-23). Our results indicate
that the nature of the P1 anchor residue of the peptide profoundly
influences the SDS susceptibility to low pH, probably because the free
energy of unfolding depends on the binding affinity between a peptide
side chain and the corresponding I-Ak site. Complexes with
the high affinity 48-61 peptide with a strong P1 anchor were highly
resistant to pH and denaturation, in marked contrast to the complexes
with substitution that have a weak P1 anchor site. These results are in
agreement with previous reports in showing that the susceptibility to
denaturation by SDS-PAGE increased considerably at low pH (24, 25) The
transition along the pH from unstable to stable complexes was
interpreted as a conformational change from a protonated class II at
low pH to an unprotonated class II at neutral pH based on its increase
uptake of aminonapthalene (24, 25).
The stable complexes of I-Ak bearing the strong binding
peptides were highly resistant to proteolysis. In contrast, those with a weaker anchor residue were highly sensitive. It was previously shown
that peptides bound to class II molecules were protected from cleavage
by proteolytic enzymes. We confirm this effect but add two important
new features. The resistance or sensitivity of the peptide bound to
I-Ak was independent of its susceptibility to enzyme
cleavage. Rather, the binding strength of the peptide with
I-Ak dictated whether the MHC molecules in the complex were
sensitive to enzymatic degradation; this result agrees with the studies on pH and photocross-linking. (A previous study on class I MHC molecules reported that peptide-empty molecules were sensitive to
proteolytic enzymes (26).)
We agree here that the propensity for SDS denaturation truly reflects a
conformational state found with complexes in solutions or in APCs. The
two conformational states may reflect in the biology of peptide
presentation by APCs. We previously showed the marked differences in
the time of persistence of SDS-stable or SDS-unstable forms of the
I-Ak molecule in APCs (11, 12). Thus, the cell sensed the
two conformational states, one of which was retained longer and
translated in higher immunogenicity than the other (12). Knowing now
that the SDS test truly reads out a physiological state adds much
credence to these results. Indeed, the survival and time of persistence of a MHC-peptide complex in the proteolysis rich environment of an APC
may well depend on the state of the molecule dictated by the binding
features of the peptide. Finally, another issue to consider is that the
more open conformation may well favor peptide exchange. A peptide bound
with low affinity, and in the loose, or SDS-unstable, state will
maintain the integrity of the dimer but allows for exchange and
reutilization by a new peptide (27). In contrast, the high affinity,
highly SDS-stable complex is not interchangeable.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviations used are:
MHC, major
histocompatibility complex;
APC, antigen-presenting cell;
PAGE, polyacrylamide gel electrophoresis;
HPLC, high pressure liquid
chromatography;
PBS, phosphate-buffered saline;
IASA, iodoazidosalicylic acid;
MES, 4- morpholineethanesulfonic
acid.
Two Structural States of Complexes of Peptide and Class II
Major Histocompatibility Complex Revealed by Photoaffinity-labeled
Peptides*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
or
chain. The
relationship held true for three different peptides in which the main
anchor residues were changed so as to affect their binding affinity for
I-Ak molecules. Thus, high affinity peptides generate a
complex in which the motion of their amino termini was restricted,
whereas complexes of low affinity peptides are more flexible. In
agreement with this observation, complexes of I-Ak with
high affinity peptides were highly resistant to proteolysis, in
contrast to those formed with weakly binding peptides, which were more
likely to be cleaved. Complexes with low affinity peptides generate a
structure with enhanced flexibility as compared with complexes with
high affinity peptides.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
plus
chains of class II MHC
molecules under various physicochemical conditions, such as pH,
temperature, and denaturing agents such as SDS. Early studies indicated
that class II molecules were resistant to denaturation under SDS-PAGE
conditions, if they contained bound peptides of high binding affinity
(1-4). Studying the I-Ak class II molecules, we found that
peptides resulted in either stable or unstable complexes with
I-Ak, i.e. SDS-resistant or SDS-sensitive
complexes (4, 5). (The complexes of peptide-class II molecules resist
or are sensitive to dissociation if subjected to the SDS-PAGE at room
temperature, i.e. stable and unstable complexes,
respectively; at 100 °C the components of the complex always
dissociate.) The conditions that determined stable or unstable SDS
complexes were related to the presence of high affinity binding
peptides in which, first, a critical P1 anchor residue was represented
by an appropriate amino acid side chain (with I-Ak, that of
aspartic acid or glutamine) and, second, the polypeptide chain was of
appropriate length (~16 residues). Actually, polyalanine peptides
containing only one aspartic acid residue bound to I-Ak
proteins and formed stable SDS complexes, but the length of the chain
was highly critical (6). Thus, binding affinity depended on two
critical interactions, that between the peptide backbone and conserved
residues on the
and
chains of I-Ak and that between
the amino acid side chain with the allele-specific site in P1 (7).
(Similar results have been found for the human HLA-DR molecules (8,
9).) The correlation, however, between binding affinity and SDS
stability was not absolute (5, 10). In our experience, we found
peptides that bound with good affinity but were highly SDS-unstable as
a result of unfavorable residues interacting with the other pockets of
the I-Ak peptide-binding site (for a complete review, see
Nelson et al. (5)).
less) was represented in the SDS-unstable component. The average
t1/2 in APCs (~20 h) was accounted by the ratio of
SDS-stable and SDS-unstable complexes. Curiously, the
koff of peptides bound to I-Ak in
solution did not correlate strictly with the time of persistence of the
complexes in APCs.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol, 20% glycerol, 0.002% bromphenol blue and run under SDS-PAGE conditions at either 100 °C or to room
temperature. Gels were fixed for 5 min, dried, and exposed to x-ray
film. Under nonboiled SDS-PAGE conditions, the stable complexes were
resistant to dissociation and the radiolabeled peptide migrated
together with the 
chains (at ~50 kDa); in the unstable
complex, the peptide dissociated and ran to the front of the gel. The
percentage of stable/unstable complexes was quantified with a
PhosphorImager system densitometer (425E Molecular Dynamics, Sunnyvale,
CA). In some experiments, complexes were recovered as described above,
buffered at pH 5.5 or 7.5 with 40 mM MES, incubated with
SDS at a final concentration of 0, 0.1, 0.5, 1, or 2% for 30 min or
6 h, neutralized, and analyzed by SDS-PAGE as described above.
-mercaptoethanol, 2% SDS, 10% glycerol, 0.001% bromphenol blue.
Half of the sample was boiled at 100 °C for 2 min and half of the
sample was kept at ambient temperature before SDS-PAGE analysis. Bands
were analyzed using a PhosphorImager system densitometer to quantify
the percentage of photolabeled peptide under boiled and nonboiled conditions.

-peptide complex. When boiled, the covalently
bound peptide will remain associated with the free
or
chain or
with both. However, a covalently bound peptide that forms part of an
SDS-unstable complex will migrate with the free
or
chain under
both nonboiling and boiling conditions. A peptide not covalently linked
to the
or
chain will migrate as part of an SDS-stable complex
in the position of 
dimer when not boiled, but it will appear at
the front of the gel under boiling conditions (i.e. the
peptide dissociates from the complex and migrates freely). A peptide
not covalently linked to an SDS-unstable complex will appear at the
front under either condition.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Properties of the complexes of IAk peptides
and
chains and the peptide. Unless otherwise stated, the
results reported with SDS-PAGE represent protein complexes not
subjected to 100 °C.)

View larger version (34K):
[in a new window]
Fig. 1.
Influence of the pH on the SDS-PAGE stability
of peptide-I-Ak complexes. Radiolabeled 48-61
peptides (having either Asp-52 or Leu-52) were incubated with purified
I-Ak for 48 h at room temperature. The complexes were
recovered by gel filtration, and an aliquot was incubated with a
solution (1:1 (v/v)) containing 40 mM MES at the indicated
pH (from 5.5 to 7.5) for 15 min at room temperature, followed by
addition of an equal volume of 2% SDS solution for 45 min. Samples
were neutralized with 250 mM Tris, pH 7.0, and analyzed by
SDS-PAGE. Left panels represent the quantitation of the
radioactive bands expressed as the percentage of stable complexes (
)
of the SDS-PAGE gels represented in the right panels. The
percentage of stable complexes for these two peptides did not change
with the pH. For the wild type 48-61 Asp-52 peptide, the percentages
varied from 91% at pH 5.5 to 95% at pH 7.5 (top panels).
For 48-61 Leu-52 peptide, the percentages ranged from 2% at pH 5.5 to
3% at pH 7.5 (bottom panels).

View larger version (33K):
[in a new window]
Fig. 2.
The SDS-PAGE stability of some
peptide-I-Ak complexes depends on pH. An aliquot of
complexes of I-Ak and radiolabeled 48-61 peptides with
Ser-52, Thr-52, or Gln-52 was incubated at the indicated pH buffer, as
described in Fig. 1. After neutralization of the samples, as described
above, they were analyzed by SDS-PAGE. The left panels show
the quantitation of the radioactive bands, expressed as a percentage of
stable complexes and of the SDS-PAGE results, shown in the right
panels. In contrast to peptides analyzed in Fig. 1, the percentage
of stable complexes for these two peptides changed with the pH of the
solution.
2 (residues 115-134) and
2 (residues 109-138) domains (15), an indication that the amino
terminus of the peptide was clearly extending beyond the
peptide-binding groove. We had also shown that the IASA probe at the
amino terminus (i.e. linked to residue 46) did not interfere
with the binding specificity of the core portion of the peptide
(residues 52-61) to I-Ak molecules. Peptides that did not
bind to I-Ak were not covalently linked by the IASA group
to I-Ak (15).
or
chain if covalently bound to
it, and in the front of the gel if not bound. Thus, when the peptide
bound to I-Ak was 48-61 Ala-52 (which is unstable on
SDS-PAGE) (Table I), most of the complexes migrated at the position of
or
chain (when not boiled). This indicates that the unstable
complexes were extensively cross-linked by the amino-terminal bound
photoprobe. After boiling, the photoprobe remained attached to the
or
chain, confirming its covalent linkage. The same results were found with 48-61 Leu-52.

View larger version (37K):
[in a new window]
Fig. 3.
Analysis of the binding and cross-linking
abilities of 46-61 and 48-61 mutant peptides at position 52 to
I-Ak class II molecules. Purified I-Ak was
incubated with IASA-46-61, IASA-48-61 Thr-52, IASA-48-61 Ser-52,
IASA-48-61 Leu-52, and IASA-48-61 Ala-52 for 48 h at room
temperature. The complexes were recovered by gel filtration,
ultraviolet-irradiated, and immunoprecipitated. Half of the sample was
kept at room temperature (not boiled (NB)) and half of the
sample was boiled (B). Complexes were analyzed by SDS-PAGE
(top panel). The percentage of stable molecule ( 
) was
94% for 46-61, 85% for 48-61, and 30% for 48-61 Thr-52, and 37%
for 48-61 Ser-52, 7% for 48-61 Leu-52, and 10% for 48-61 Ala-52.
When samples were boiled, the percentages of label covalently linked to
the
and/or
chain were 9, 6, 30, 45, 60, and 80%, respectively.
The bottom panel shows the relationship between the
percentage of a complex forming SDS-PAGE-stable complex and the
percentage of the photoactivatable peptide that was covalently
linked.

dimer regardless of whether it is covalently bound by the
photoprobe (under conditions in which the complex is not boiled).
However, after boiling, the peptide will be found associated with the
or
chain if covalently bound, or at the front if not bound. As
it is shown in Fig. 3 (NB (nonboiled)) peptide 48-61 or
46-61 formed stable complexes with I-Ak, but most of them
were not covalently bound to the
or
chain, and appeared in the
front of the gel (Fig. 3, lanes B (boiled)).
chain. These
corresponded mostly with the unstable complex (i.e. the
percentage remaining in the position of the
or
chain did not
increase after boiling: see legend to Fig. 3). (The 48-61 Ser-52
peptide despite being pure showed some interaction with the gel as
indicated by the extra band. Note that when the sample was boiled a
fraction of the peptide from the stable complex again had an abnormal
migration (Fig. 3).) Confirming the above results with 48-61 Asp-52
and 48-61 Ala-52, most of the peptide covalently associated with class
II molecule (
-chain) was accounted by the unstable complexes,
whereas only a small fraction of stable complexes were covalently bound
(Fig. 3). Table I summarizes all the experiments.
and
chain. The same findings applied to another self-peptide, that from
ryudocan residues 84-101; the wild type peptide with an aspartic acid
at residue 90 was SDS-stable but showed a poor covalent linkage to
I-Ak molecules. Having the peptide with an alanine
substitution at residue 90 resulted in an SDS-unstable complex that was
covalently associated with I-Ak molecules.

View larger version (63K):
[in a new window]
Fig. 4.
Cross-linking abilities of other peptides to
I-Ak class II molecules also correlate with their SDS
stability properties. Purified I-Ak was incubated with
IASA Hsp 28-41, IASA-Hsp 28-41 Ala-32, IASA-Ryu 84-101, and IASA-Ryu
84-101 Ala-90 peptides for 48 h at room temperature and then
ultraviolet light-irradiated and immunoprecipitated. Samples were
divided into not boiled (NB) and boiled (B), as
described in Fig. 3, and analyzed by SDS-PAGE. The percentages of
stable molecule ( 
) were 81% for Hsp 28-41, 12% for Hsp 28-41
Ala-32, 94% for Ryu 84-101, and 16% for Ryu 84-101 Ala-90. The
percentages of cross-linking when the samples were boiled were 9, 60, 2, and 82%, respectively.

View larger version (20K):
[in a new window]
Fig. 5.
48-61 peptides show differential sensitivity
to chymotrypsin. The six panels show a representative result taken
from three to five different experiments. The 125I-labeled
peptides were bound to I-Ak, and the complex was purified
and incubated with chymotrypsin at the indicated concentrations. The
amount of label remaining associated with I-Ak was
determined at the various times. A wide range of chymotrypsin were used
in these sets of experiments. Indicated with 48-61 Asp-52 and 48-61
Ser-52 are the highest amounts used. Indicated with 48-61 Ala-52 are
the results with 0.2 and 0.5 mg/ml. Other experiments examined the
sensitivity of the 48-61 Ala-52 complexes with a higher concentration
of chymotrypsin. For example, in one experiment, treating the 48-61
Ala-52 complexes for 3 h with 1 and 2.5 mg/ml resulted in 24 and
16% of peptide associated with I-Ak at 3 h,
respectively. The untreated complex showed 48% of the peptide bound to
I-Ak. Indicated in the bottom panels are the
results with the two peptides resistant to chymotrypsin cleavage
(discussed in the text).

View larger version (27K):
[in a new window]
Fig. 6.
Peptides bound to I-Ak are
resistant to chymotrypsin. In all the six panels,
125I-labeled peptides bound to I-Ak were either
not treated (open symbols) or treated with chymotrypsin
(closed symbols) for a period of 2 h. The complex was
isolated using monoclonal antibody 40F bound to Sepharose. The
Sepharose beads were washed extensively and then placed in a solution
of 0.1% trifluoroacetic acid; the supernatant was examined by reverse
phase HPLC. a, elution of 125I-labeled 48-61
after incubation with 5 mg/ml chymotrypsin: the amount of complex
recovered was 98% (untreated peptide migrated at fraction 29, and
peptide after chymotrypsin migrated at fraction 21). b,
elution of 48-61 Ser-52 after 1 mg/ml chymotrypsin: recovery of 88%
(untreated and treated peptide eluted at fraction 29 and 21, respectively). Identical results were found using 5 mg/ml chymotrypsin.
c, elution of 48-61 Ala-52 after 0.2 mg/ml chymotrypsin:
recovery was 40% (untreated and treated peptide eluted at fractions 30 and 23, respectively). d, elution of 48-61 Leu 52 after 0.1 mg/ml chymotrypsin: recovery was 20% (untreated and treated peptide
eluted at fractions 33 and 27, respectively).
1 of 2) (see Table I), because of the
aspartic acid at the fifth residue from the amino terminus. The complex
of it with I-Ak was highly resistant to chymotrypsin, even
at a 10 mg/ml concentration of enzyme. In contrast, a peptide that was
similar but had a serine instead of the aspartic acid bound less well
(relative inhibitory capacity
1 of 7.1). The complex was
much more sensitive to chymotrypsin (Fig. 5). Thus, the loss of the
peptide from I-Ak was independent of whether it is cleaved
by the enzyme.

View larger version (72K):
[in a new window]
Fig. 7.
I-Ak molecules represented in the
SDS-unstable component are more sensitive to chymotrypsin.
35S-Labeled I-Ak molecules from APCs were
isolated, treated with the indicated concentrations of chymotrypsin,
and subjected to SDS-PAGE. Each lane shows the I-Ak
molecule after incubation in the sample buffer at room temperature (not
boiled (NB)) or at 100 °C (boiled (B)). There
was no loss of stable I-Ak molecules (for example,
area = 5778 without treatment, compared to 5579 at 1 mg/ml
chymotrypsin). The percentage recovery after chymotrypsin, in the NB
lanes, were 48, 29, 18, and 20% at 0.01, 0.1, 0.5, and 1 mg/ml
chymotrypsin, respectively. The percentages of stable molecules were
58% in the untreated sample and 77, 82, 87, and 85% in samples
treated with the concentrations of chymotrypsin described above. Note
that some splitting of the
chain occurred at the 0.5 and 1.0 mg/ml
concentrations.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Pathology,
Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-7440; Fax: 314-362-4096; E-mail: unanue@pathology.wustl.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Sadegh-Nasseri, S.,
and Germain, R. N.
(1991)
Nature
353,
167-170[CrossRef][Medline]
[Order article via Infotrieve]
2.
Germain, R. N.,
and Hendrix, L. R.
(1991)
Nature
353,
134-139[CrossRef][Medline]
[Order article via Infotrieve]
3.
Stern, L. J.,
and Wiley, D. C.
(1992)
Cell
68,
465-477[CrossRef][Medline]
[Order article via Infotrieve]
4.
Nelson, C. A.,
Petzold, S. J.,
and Unanue, E. R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1227-1231 5.
Nelson, C. A.,
Viner, N. J.,
and Unanue, E. R.
(1996)
Immunol. Rev.
151,
81-105[CrossRef][Medline]
[Order article via Infotrieve]
6.
Nelson, C. A.,
Viner, N. J.,
Young, S. P.,
Petzold, S. J.,
and Unanue, E. R.
(1996)
J. Immunol.
157,
755-762[Abstract]
7.
Fremont, D. H.,
Monnaie, D.,
Nelson, C. A.,
Hendrickson, W. A.,
and Unanue, E. R.
(1998)
Immunity
8,
305-317[CrossRef][Medline]
[Order article via Infotrieve]
8.
Jardetzky, T.,
Gorga, J.,
Busch, R.,
Rothbard, J.,
Strominger, J.,
and Wiley, D.
(1990)
EMBO J.
9,
1797-1806[Medline]
[Order article via Infotrieve]
9.
Natarajan, S. K.,
Stern, L. J.,
and Sadegh-Nasseri, S.
(1999)
J. Immunol.
162,
3463-3470 10.
Verreck, F. A.,
Vermeulen, C.,
Poel, A. V.,
Jorritsma, P.,
Amons, R.,
Coligan, J. E.,
Drijfhout, J. W.,
and Koning, F.
(1996)
Int. Immunol.
8,
397-404 11.
Nelson, C. A.,
Petzold, S. J.,
and Unanue, E. R.
(1994)
Nature
371,
250-252[CrossRef][Medline]
[Order article via Infotrieve]
12.
Carrasco-Marín, E.,
Shimizu, J.,
Kanagawa, O.,
and Unanue, E. R.
(1996)
J. Immunol.
156,
450-458[Abstract]
13.
Luescher, I. F.,
and Unanue, E. R.
(1990)
J. Immunol. Methods
135,
233-245[CrossRef][Medline]
[Order article via Infotrieve]
14.
Luescher, I. F.,
Allen, P. M.,
and Unanue, E. R.
(1988)
Proc. Natl. Acad Sci. U. S. A.
85,
871-874 15.
Luescher, I. F.,
Crimmins, D. L.,
Schwartz, B. D.,
and Unanue, E. R.
(1990)
J. Biol. Chem.
265,
11177-11184 16.
Kessler, B. M.,
Bassanini, P.,
Cerottini, J. C.,
and Luescher, I. F.
(1997)
J. Exp. Med.
185,
629-640 17.
Harding, C. V.,
Roof, R. W.,
Allen, P. M.,
and Unanue, E. R.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2740-2744 18.
Donnermeyer, D. L.,
and Allen, P. M.
(1989)
J. Immunol.
142,
1063-1068[Abstract]
19.
Mouritsen, S.,
Meldal, M.,
Werdelin, O.,
Hansen, A. S.,
and Buus, S.
(1992)
J. Immunol.
194,
1987-1993
20.
Caflisch, A.,
and Karplus, M.
(1995)
J. Mol. Biol.
252,
672-708[CrossRef][Medline]
[Order article via Infotrieve]
21.
Goto, Y.,
and Fink, A. L.
(1989)
Biochemistry
28,
945-952[CrossRef][Medline]
[Order article via Infotrieve]
22.
Kim, P. S.,
and Baldwin, R. L.
(1990)
Annu. Rev. Biochem.
59,
631-660[CrossRef][Medline]
[Order article via Infotrieve]
23.
Caflisch, A.,
and Karplus, M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1746-1750 24.
Runnels, H. A.,
Moore, J. C.,
and Jensen, P. E.
(1996)
J. Exp. Med.
183,
127-136 25.
Boniface, J. J.,
Lyons, D. S.,
Wettstein, D. A.,
Allbritton, N. L.,
and Davis, M. M.
(1996)
J. Exp. Med.
183,
119-126 26.
Bouvier, M.,
and Wiley, D. C.
(1998)
Nat. Struct. Biol.
5,
377-384[CrossRef][Medline]
[Order article via Infotrieve]
27.
Natarajan, S. K.,
Assadi, M.,
and Sadegh-Nasseri, S.
(1999)
J. Immunol.
162,
4030-4036
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. B. Lovitch, Z. Pu, and E. R. Unanue Amino-Terminal Flanking Residues Determine the Conformation of a Peptide-Class II MHC Complex. J. Immunol., March 1, 2006; 176(5): 2958 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Peterson, R. J. DiPaolo, O. Kanagawa, and E. R. Unanue Cutting Edge: A Single MHC Anchor Residue Alters the Conformation of a Peptide-MHC Complex Inducing T Cells That Survive Negative Selection J. Immunol., May 15, 2001; 166(10): 5874 - 5877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Velazquez, R. DiPaolo, and E. R. Unanue Quantitation of Lysozyme Peptides Bound to Class II MHC Molecules Indicates Very Large Differences in Levels of Presentation J. Immunol., May 1, 2001; 166(9): 5488 - 5494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Latek, S. J. Petzold, and E. R. Unanue Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules PNAS, September 29, 2000; (2000) 210384197. [Abstract] [Full Text] |
||||
![]() |
R. Gugasyan, C. Velazquez, I. Vidavsky, B. M. Deck, K. van der Drift, M. L. Gross, and E. R. Unanue Independent Selection by I-Ak Molecules of Two Epitopes Found in Tandem in an Extended Polypeptide Antigen J. Immunol., September 15, 2000; 165(6): 3206 - 3213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Latek, S. J. Petzold, and E. R. Unanue Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules PNAS, October 10, 2000; 97(21): 11460 - 11465. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||